-
Mashup Score: 2
Analyses of large population-based cohorts and clinical trials show that using polygenic scores to account for variability in PSA levels improves detection of prostate cancer, suggesting an approach for enhancing screening accuracy.
Source: NatureCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0Urology Times 50 Innovations Series: PSA testing - 2 year(s) ago
“The fact that it was a simple blood test, it was absolutely objective, and it was…non-invasive…made it very attractive,” says William J. Catalona, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Genetically-adjusted PSA may address overdiagnosis/overtreatment issues of prostate cancer screening - 2 year(s) ago
Results shared during the 2022 AACR Annual Meeting suggested that genetic adjustment of prostate-specific antigen may reduce overdiagnosis of prostate cancer, de-escalate invasive testing, and improve the detection of aggressive disease.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Moving transperineal prostate biopsy into the clinic - 2 year(s) ago
Learning curve for technique is short, but capital expenditures are required.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Laboratory test-based model shows predictive accuracy for acute kidney injury after cardiac surgery - 2 year(s) ago
“[The prediction model] worked way better than we expected that it would work,” says Sevag Demirjian, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0
“I think the take home message is that [IsoPSA is] an easy test to use,” says Eric A. Klein, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1
“I think the take home message is that [IsoPSA is] an easy test to use,” says Eric A. Klein, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0IsoPSA leads to reduction in prostate biopsy recommendations - 2 year(s) ago
“The idea is to develop strategies that reduce the likelihood of needing a biopsy or improving the sensitivity of the biopsy to find a high-grade cancer, one that’s treatable,” says Eric A. Klein, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 3IsoPSA leads to reduction in prostate biopsy recommendations - 2 year(s) ago
“The idea is to develop strategies that reduce the likelihood of needing a biopsy or improving the sensitivity of the biopsy to find a high-grade cancer, one that’s treatable,” says Eric A. Klein, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0IsoPSA leads to reduction in prostate biopsy recommendations - 2 year(s) ago
“The idea is to develop strategies that reduce the likelihood of needing a biopsy or improving the sensitivity of the biopsy to find a high-grade cancer, one that’s treatable,” says Eric A. Klein, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
SCI members @johnwitte @Linda_Kachuri & others aim to make #PSAscreening more accurate by calibrating #PSAlevels to each man’s genetics. This could reduce overdiagnosis & better predict aggressive disease. https://t.co/XNFKOtjwX2 #CancerScreening #PersonalizedMedicine https://t.co/Ifxmj42NFY